Tolvaptan in later-stage autosomal dominant polycystic kidney disease

REPRISE Trial Investigators

Research output: Contribution to journalArticlepeer-review

198 Scopus citations

Fingerprint

Dive into the research topics of 'Tolvaptan in later-stage autosomal dominant polycystic kidney disease'. Together they form a unique fingerprint.

Medicine & Life Sciences